Presentation Information
[P-66]antiefinはmRNA-LNPワクチン誘発性炎症を抑制する新規脂肪酸である
*Keigo Iemitsu1,2, Masashi Hotta1, Yutaro Saito3, Ken Yoshii1, Yuki Hirayama1,4, Mengqi Wang1,2, Shinsuke Sando3,5, Jun Kunisawa1,2,4,6,7,8,9,10 (1. Laboratory of Vaccine Materials and Laboratory of Gut Environmental System, Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health, and Nutrition, 2. Graduate School of Medicine, The University of Osaka, 3. Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 4. Graduate School of Pharmaceutical Sciences, The University of Osaka, 5. Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 6. Graduate School of Science, The University of Osaka, 7. The Institute of Medical Science, The University of Tokyo, 8. Graduate School of Medicine, Kobe University, 9. Research Organization for Nano and Life Innovation, Waseda University, 10. Graduate School of Dentistry, The University of Osaka)
